Mini Review - (2023) Volume 13, Issue 5
Received: 04-Sep-2023, Manuscript No. jsmds-23-114924;
Editor assigned: 06-Sep-2023, Pre QC No. P-114924;
Reviewed: 18-Sep-2023, QC No. Q-114924;
Revised: 23-Sep-2023, Manuscript No. R-114924;
Published:
30-Sep-2023
, DOI: 10.37421/2161-0673.2023.13.327
Citation: Sharma, Aradhya. “Unlocking the Heart’s Secrets:
Biomarkers in Sports Cardiology.” J Sports Med Doping Stud 13 (2023): 327.
Copyright: © 2023 Sharma A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This paper delves into the intricate realm of sports cardiology, specifically focusing on the emerging field of cardiac biomarkers. The study explores the relevance and application of various biomarkers in assessing cardiovascular health among athletes. Through an extensive literature review, we investigate the utilization of biomarkers in the diagnosis, monitoring and risk stratification of cardiac conditions in athletes. This review aims to shed light on the pivotal role of biomarkers in enhancing the early detection and management of cardiovascular issues in sports medicine, ultimately contributing to the holistic well-being of athletes.
Sports cardiology • Cardiac biomarkers • Athlete cardiovascular health • Troponins • Myoglobin
The field of sports cardiology has witnessed remarkable advancements in recent years, driven by the ever-growing number of individuals engaging in rigorous physical activities, from professional athletes to weekend warriors. Athletes place unique demands on their cardiovascular systems, triggering adaptations that can sometimes blur the line between physiological changes and pathological conditions. This ambiguity underscores the need for precise diagnostic tools and herein lies the essence of our study. Cardiac biomarkers have emerged as critical tools in the quest to understand, monitor and safeguard athletes' cardiovascular health. These biomarkers, often proteins or molecules detectable in the blood, provide valuable insights into the heart's condition, offering both a snapshot and a dynamic view of its function and integrity. This paper embarks on a comprehensive journey through the literature to unravel the intricate role of cardiac biomarkers in sports cardiology, aiming to shed light on their significance, limitations and the promise they hold in enhancing athletes' well-being [1].
Sports cardiology is a dynamic and evolving field, addressing the unique cardiovascular demands imposed by athletic activities. Athletes' hearts adapt to intense physical training, resulting in structural and functional alterations that can sometimes mimic cardiac pathology. This mimicry underscores the importance of accurate diagnostic tools, such as cardiac biomarkers, to differentiate physiological adaptations from pathological conditions. This literature review explores the current understanding of cardiac biomarkers in sports cardiology, emphasizing their significance in risk assessment, diagnosis and monitoring.
Biomarkers in sports cardiology
Troponins: Cardiac troponins, specifically troponin I and T, have gained prominence as sensitive indicators of myocardial injury. In athletes, elevated troponin levels may signify exercise-induced cardiac stress, making it crucial to establish baseline values for each athlete. The challenge lies in distinguishing between benign troponin elevations and those indicative of myocardial pathology [2].
Natriuretic peptides: Brain Natriuretic Peptide (BNP) and N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) have demonstrated utility in diagnosing heart failure and left ventricular dysfunction. In sports cardiology, they aid in identifying athletes at risk of developing exercise-induced cardiac dysfunction, particularly in endurance sports [3].
Creatine Kinase-MB (CK-MB): Although less specific than troponins, CK-MB can indicate myocardial damage. Monitoring CK-MB levels before and after strenuous exercise can provide insights into cardiac stress and recovery.
Myoglobin: Myoglobin is a rapidly released marker of muscle injury. While not specific to the heart, it can contribute to a comprehensive assessment of an athlete's overall condition.
High-sensitivity C-Reactive Protein (hs-CRP): Elevated hs-CRP levels are associated with inflammation, which may be linked to cardiovascular risk. Monitoring this biomarker can help identify athletes with increased susceptibility to cardiovascular events [4].
In the realm of sports cardiology, the identification and interpretation of cardiac biomarkers present both opportunities and challenges. Troponins, for instance, have gained prominence as sensitive indicators of myocardial injury, but their interpretation in athletes is a nuanced task. Elevated troponin levels may be a result of strenuous exercise rather than pathological conditions. Hence, the establishment of baseline values specific to each athlete's physiology is crucial. Natriuretic peptides, on the other hand, have proven their worth in diagnosing heart failure, even in the athletic population. These biomarkers can aid in identifying athletes at risk of exercise-induced cardiac dysfunction, especially in endurance sports where cardiovascular demands are high [5]. Creatine Kinase-MB and myoglobin offer additional dimensions to the assessment of an athlete's cardiovascular health, although they lack the specificity of troponins. Monitoring these markers before and after intense exercise can provide insights into cardiac stress and recovery. High-Sensitivity C-Reactive Protein (hs-CRP) has also emerged as an essential biomarker, reflecting inflammation that may be associated with cardiovascular risk. By monitoring hs-CRP levels, sports cardiologists can identify athletes with an increased susceptibility to cardiovascular events, facilitating timely intervention and risk reduction strategies. However, challenges persist in the standardization of reference ranges for these biomarkers in athletes, considering their unique physiology and training regimens. The risk of misinterpretation and over diagnosis must be carefully addressed to ensure that athletes receive appropriate medical guidance without unnecessary concern [6].
The study underscores the growing significance of cardiac biomarkers in the ever-evolving field of sports medicine. These biomarkers offer a window into the athlete's cardiovascular health, aiding in the early detection and management of cardiac issues. Nevertheless, their application must be guided by rigorous research and the establishment of athlete-specific reference ranges, ensuring that their interpretation aligns with the unique physiology of those engaged in intense physical activities. As sports cardiology continues to evolve, so too will the role of cardiac biomarkers in safeguarding the hearts of athletes. Their promise in distinguishing between physiological adaptations and pathological conditions presents an exciting frontier in sports medicine. With on-going research and collaborative efforts among sports cardiologists, researchers and athletes themselves, these biomarkers may hold the key to unlocking the heart's secrets, paving the way for healthier and more informed athletic journeys.
None.
There are no conflicts of interest by author.
Journal of Sports Medicine & Doping Studies received 1022 citations as per Google Scholar report